A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
64 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Pleven, Bulgaria
- Facility name not stated
Plovdiv, Bulgaria
- Facility name not stated
Rousse, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Stara Zagora, Bulgaria
- Facility name not stated
Targovishte, Bulgaria
- Facility name not stated
Varna, Bulgaria
- Facility name not stated
Medellín, Antioquia, Colombia
- Facility name not stated
Bogota, Cundinamarca, Colombia
- Facility name not stated
Bucaramanga, Santander Department, Colombia
- Facility name not stated
Frankfurt, Germany
- Facility name not stated
Halle, Germany
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Kecskemét, Hungary
- Facility name not stated
Mezőkövesd, Hungary
- Facility name not stated
Nyíregyháza, Hungary
- Facility name not stated
Veszprém, Hungary
- Facility name not stated
Mexico City, Col Roam Sur, Mexico
- Facility name not stated
Mexico City, Del Cuautemoc, Mexico
- Facility name not stated
León, Guanajuato, Mexico
- Facility name not stated
Guadalajara, Jalisco, Mexico
- Facility name not stated
Madero, Mexico DF, Mexico
- Facility name not stated
Morelia, Michoacán, Mexico
- Facility name not stated
Monterrey, Nuevo León, Mexico
- Facility name not stated
San Luis Potosí City, San Luis Potosi, C.P., Mexico
- Facility name not stated
Mérida, Yucatán, Mexico
- Facility name not stated
Mexico City, Mexico
- Facility name not stated
Otahuhu, Auckland, New Zealand
- Facility name not stated
Wellington, New Zealand
- Facility name not stated
Grodzisk, Mazowiecki, Poland
- Facility name not stated
Krakow, Okulickiego, Poland
- Facility name not stated
Bialystok, Poland
- Facility name not stated
Elblag, Poland
- Facility name not stated
Krakow, Poland
- Facility name not stated
Lublin, Poland
- Facility name not stated
Nadarzyn, Poland
- Facility name not stated
Poznan, Poland
- Facility name not stated
Skierniewice, Poland
- Facility name not stated
Sosnowiec, Poland
- Facility name not stated
Stalowa Wola, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2013
- Primary completion
- 31 Dec 2014
- Completion
- 28 Feb 2015
- Last update posted
- 17 Mar 2021
- Registered enrollment
- 322
- Registry id
- NCT01851707
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.